3.4855
price up icon2.82%   0.0955
 
loading
Dna X Inc stock is traded at $3.4855, with a volume of 4,332. It is up +2.82% in the last 24 hours and down -19.50% over the past month. DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
See More
Previous Close:
$3.39
Open:
$3.75
24h Volume:
4,332
Relative Volume:
0.17
Market Cap:
$5.19M
Revenue:
$27.40M
Net Income/Loss:
$-17.12M
P/E Ratio:
-0.0326
EPS:
-106.8896
Net Cash Flow:
$-24.99M
1W Performance:
-7.79%
1M Performance:
-19.50%
6M Performance:
-38.53%
1Y Performance:
-67.18%
1-Day Range:
Value
$3.4082
$3.75
1-Week Range:
Value
$3.32
$3.80
52-Week Range:
Value
$2.5211
$16.97

Dna X Inc Stock (SONM) Company Profile

Name
Name
Dna X Inc
Name
Phone
650-378-8100
Name
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Name
Employee
4
Name
Twitter
@sonimtech
Name
Next Earnings Date
2026-08-14
Name
Latest SEC Filings
Name
SONM's Discussions on Twitter

Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SONM icon
SONM
Dna X Inc
3.4855 5.16M 27.40M -17.12M -24.99M -106.89
MSFT icon
MSFT
Microsoft Corp
495.40 3.66T 318.27B 125.22B 72.92B 16.79
ORCL icon
ORCL
Oracle Corp
150.52 441.52B 67.36B 17.31B -23.69B 5.8248
PLTR icon
PLTR
Palantir Technologies Inc
174.04 411.02B 5.22B 2.29B 2.69B 0.8876
CRWD icon
CRWD
Crowdstrike Holdings Inc
216.95 225.83B 5.09B -24.89M 1.43B -0.0471
FTNT icon
FTNT
Fortinet Inc
160.01 118.01B 7.11B 1.95B 2.44B 2.5883

Dna X Inc Stock (SONM) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-31-19 Downgrade Oppenheimer Outperform → Perform
Jul-18-19 Initiated B. Riley FBR Buy
Jul-09-19 Upgrade National Securities Neutral → Buy
Jun-10-19 Initiated National Securities Neutral
Jun-04-19 Initiated Lake Street Buy
Jun-04-19 Initiated Oppenheimer Outperform
View All

Dna X Inc Stock (SONM) Latest News

pulisher
Aug 14, 2026

Sonim Technologies delays quarterly filing amid consolidation - TipRanks

Aug 14, 2026
pulisher
Aug 14, 2026

DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView

Aug 14, 2026
pulisher
Aug 13, 2026

Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com

Aug 13, 2026
pulisher
Aug 13, 2026

DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan

Aug 13, 2026
pulisher
Aug 11, 2026

Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance

Aug 11, 2026
pulisher
Aug 08, 2026

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛

Aug 08, 2026
pulisher
Aug 05, 2026

How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica

Aug 05, 2026
pulisher
Aug 03, 2026

Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK

Aug 03, 2026
pulisher
Jul 30, 2026

Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan

Jul 30, 2026
pulisher
Jul 24, 2026

DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView

Jul 24, 2026
pulisher
Jul 23, 2026

VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK

Jul 23, 2026
pulisher
Jul 23, 2026

VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 23, 2026
pulisher
Jul 23, 2026

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times

Jul 23, 2026
pulisher
Jul 23, 2026

Restriction-enzyme DNA fingerprinting method explained - Encyclopedia Britannica

Jul 23, 2026
pulisher
Jul 20, 2026

12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga

Jul 20, 2026
pulisher
Jul 14, 2026

DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research

Jul 14, 2026
pulisher
Jul 05, 2026

SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et

Jul 05, 2026
pulisher
Jul 03, 2026

Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail

Jul 03, 2026
pulisher
Jul 02, 2026

12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga

Jul 02, 2026
pulisher
Jul 02, 2026

DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart

Jul 02, 2026
pulisher
Jul 02, 2026

DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView

Jul 02, 2026
pulisher
Jul 02, 2026

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times

Jul 02, 2026
pulisher
Jul 01, 2026

SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et

Jul 01, 2026
pulisher
Jun 30, 2026

Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS

Jun 30, 2026
pulisher
Jun 29, 2026

Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS

Jun 29, 2026
pulisher
Jun 28, 2026

DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Applied DNA Sciences Named B2i Digital Featured Company to Share BNB-Focused Treasury Shift with Investors - The National Law Review

Jun 28, 2026
pulisher
Jun 27, 2026

Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com

Jun 27, 2026
pulisher
Jun 26, 2026

Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga

Jun 26, 2026
pulisher
Jun 26, 2026

WhatsApp CEO Kunal Shah said Indians don’t value time. Sanskrit scholar responds - ThePrint

Jun 26, 2026
pulisher
Jun 25, 2026

Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Alex Murdaugh defense points to unknown male DNA in push for new testing - 930 WFMD Free Talk

Jun 25, 2026
pulisher
Jun 15, 2026

SONM Q3 2024 Earnings: Loss Narrows Significantly, Beats ExpectationsEarnings Miss Streak - newsline.com

Jun 15, 2026
pulisher
Jun 15, 2026

Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant - Stock Titan

Jun 15, 2026
pulisher
Jun 12, 2026

[EFFECT] DNA X, Inc. SEC Filing - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

DNA X | EFFECT: Others - Moomoo

Jun 12, 2026
pulisher
Jun 11, 2026

DNA X Inc. (SONM) Faces Downside Pressure as Support Levels ApproachRVOL Spike - newsline.com

Jun 11, 2026
pulisher
Jun 08, 2026

DNA X (SONM) deregisters 350M common shares tied to Chardan resale - Stock Titan

Jun 08, 2026
pulisher
Jun 07, 2026

DNA Research Shows Your Muscles Remember How Strong and Fit You Once Were - inc.com

Jun 07, 2026
pulisher
Jun 05, 2026

11 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga

Jun 05, 2026
pulisher
Jun 05, 2026

12 Information Technology Stocks Moving In Friday's Pre-Market Session - Benzinga

Jun 05, 2026
pulisher
Jun 05, 2026

DNA X, Inc. (formerly Sonim Technologies) Terminates Material Definitive Agreement – SEC Form 8-K Filing June 2026 - Minichart

Jun 05, 2026
pulisher
Jun 04, 2026

Sonim Technologies Ends Major Equity Purchase Agreement - TipRanks

Jun 04, 2026
pulisher
Jun 04, 2026

DNA X Ends $500 Million ChEF Equity Facility and Related Registration Rights With Chardan - TradingView

Jun 04, 2026
pulisher
Jun 04, 2026

DNA X (NASDAQ: SONM) terminates $500M Chardan equity facility - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Natera Inc stock (US6323071042): insider sales and new oncology board appointments in focus - AD HOC NEWS

Jun 04, 2026

Dna X Inc Stock (SONM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
XYZ XYZ
$82.88
price down icon 0.25%
$105.26
price down icon 0.97%
$277.68
price up icon 8.88%
$421.50
price up icon 2.37%
NET NET
$315.78
price down icon 4.55%
$160.01
price down icon 3.28%
Cap:     |  Volume (24h):